Back to Treatments

Treatment

Roflumilast (PDE4 Inhibitor)

1
Conditions
4
Trials
15K
Participants
55%
Average Safety

Condition Evidence

COPD

4 trials · 15K participants

60% effectiveness · 55% safety
Roflumilast (PDE4 Inhibitor) | DFDA